glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Activation of the eIF2α/ATF4 axis

Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect

SKU: 17828996596 · From lagence-mr.com